Literature DB >> 28683978

Pharmacodynamics and Follow-Up Period in the Treatment of Human Trypanosoma Cruzi Infections With Posaconazole.

Julio A Urbina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28683978     DOI： 10.1016/j.jacc.2017.03.611

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

1.  Amlodipine Increases the Therapeutic Potential of Ravuconazole upon Trypanosoma cruzi Infection.

Authors:  Yara Almeida Machado; Maria Terezinha Bahia; Ivo Santana Caldas; Ana Lia Mazzeti; Rômulo Dias Novaes; Breno Raimundo Vilas Boas; Lorena Júnia de Souza Santos; Olindo Assis Martins-Filho; Marcos José Marques; Lívia de Figueiredo Diniz
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

2.  Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.

Authors:  Laura Friggeri; Tatiana Y Hargrove; Girish Rachakonda; Anna L Blobaum; Paxtyn Fisher; Gabriel Melo de Oliveira; Cristiane França da Silva; Maria de Nazaré C Soeiro; W David Nes; Craig W Lindsley; Fernando Villalta; F Peter Guengerich; Galina I Lepesheva
Journal:  J Med Chem       Date:  2018-11-30       Impact factor: 7.446

3.  Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.

Authors:  Irene Roquero; Juan Cantizani; Ignacio Cotillo; M Pilar Manzano; Albane Kessler; J Julio Martín; Case W McNamara
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-05-22       Impact factor: 4.077

Review 4.  Advances in preclinical approaches to Chagas disease drug discovery.

Authors:  Fernando Villalta; Girish Rachakonda
Journal:  Expert Opin Drug Discov       Date:  2019-08-14       Impact factor: 6.098

Review 5.  Disruption of Intracellular Calcium Homeostasis as a Therapeutic Target Against Trypanosoma cruzi.

Authors:  Gustavo Benaim; Alberto E Paniz-Mondolfi; Emilia Mia Sordillo; Nathalia Martinez-Sotillo
Journal:  Front Cell Infect Microbiol       Date:  2020-02-14       Impact factor: 5.293

Review 6.  Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers.

Authors:  Giuliana Muraca; Ignacio Rivero Berti; María L Sbaraglini; Wagner J Fávaro; Nelson Durán; Guillermo R Castro; Alan Talevi
Journal:  Front Chem       Date:  2020-11-26       Impact factor: 5.221

7.  Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box.

Authors:  Juan Cantizani; Pablo Gamallo; Ignacio Cotillo; Raquel Alvarez-Velilla; Julio Martin
Journal:  PLoS Negl Trop Dis       Date:  2021-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.